ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) P... (5-50 info@bioinvent.com http://w...)

(Date:5/23/2013)... 23, 2013 PuraMed BioScience ® , ... of over-the-counter (OTC) medicinal and healthcare products, announced ... the company based on low market capitalization valuation. ... All Natural Product to Treat Migraine Headaches ... Prescription Competitor , Currently Available Nationwide at ...

(Date:5/23/2013)... HILLS, Calif. , May 23, 2013 Saddleback ... recently became the first hospital on the ... robotic technology. This new surgical option provides women with ... Marc Winter , M.D., ... gynecologist and surgeon and medical director of minimally invasive ...

(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy. (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...

(Date:5/23/2013)... 23, 2013 Pusan National University Yangsan ... biotherapeutics and contract research company focused on research ... announced today a publication reporting the induction of ... oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene devacirepvec; Jennerex ... in the May 15 th , 2013 issue ...

Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2 PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3 Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2 Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2 NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3 Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2 Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3

[0] PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 [0] Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy [0] NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer [0] Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment

... 8 Beckman Coulter, Inc. (NYSE: ... of products that simplify, automate, and innovate complex ... Coulter,s chairman, president and chief executive officer, will ... Lynch Healthcare Conference on Wednesday, May 13, 2009 ...

... Yongye Biotechnology,International, Inc. (OTC Bulletin Board: YGYB, ... distributor of plant and animal nutrient products ... that it closed a private placement,financing with ... of the same investors who participated in ...

... 8 PharmAthene, Inc. (NYSE Amex: PIP ... and chemical threats, announced a date change for its ... 2009 financial results will now be released on Friday, ... call to discuss its first quarter 2009 financial results. ...

Cached Biology Technology:Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance 2 Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance 3

Beckman Coulter to Present at the Bank of America and Merrill Lynch Healthcare Conference Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

(Date:5/24/2013)... of 500 leading water scientists from around the world ... "in the short span of one or two generations, ... will be living under the handicap of severe pressure ... which there is no substitute. This handicap will be ... scientists bluntly pointed to chronic underlying problems led by ...

(Date:5/23/2013)... RICHLAND, Wash. Pacific Northwest National Laboratory honored ... and commercialization of intellectual property at PNNL,s annual ... , The Department of Energy national laboratory ... Year for his work developing battery materials that ... to the electrical grid, and reduce the time ...

(Date:5/23/2013)... suppresses lipid synthesis in the liver, UC Irvine endocrinologists ... liver diseases. , With this finding, Dr. Ellis ... in the field. Study results appear in the May ... , "The dogma in the steroid receptor field for ... the nucleus respond to steroid hormones by regulating genes ...

Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3 A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4 PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2 UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2

[0] A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists [1] PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace [0] UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis

... cancer, including stomach, liver and colon, are far more common ... differences in lifestyle, such as diet and smoking, may account ... are rooted in basic biological differences between men and women. ... shows that treating male mice with estrogen dramatically lowers their ...

... giant seaweeds, are spreading fast, with harmful effects on ... the Mediterranean seabed. Some native species, such as sea ... invasion, but only during its early stages, or when ... carried out a study to look at the ability ...

... If genetically modified Atlantic salmon were to escape ... their genes into the wild, Canadian researchers have found. ... the potential reproductive implications of GM salmon as they ... of growth-enhancing transgenic technologies has long been of interest ...

Cached Biology News:Study explains why men are at higher risk for stomach cancer 2 Study explains why men are at higher risk for stomach cancer 3 Sea urchins cannot control invasive seaweeds 2 First study into GM Atlantic salmon mating reveals danger of escape to wild gene pool 2

Study explains why men are at higher risk for stomach cancer Sea urchins cannot control invasive seaweeds First study into GM Atlantic salmon mating reveals danger of escape to wild gene pool

The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...

MOUSE ANTI HUMAN MOC31:AZIDE FREE...

... mycobacteria in Complete Freund's adjuvant attract macrophages ... which enhances the immuneresponse. For this reason, ... the initial injections; Incomplete Freund's adjuvant is ... in saline) are typically mixed with an ...

HiTrap Streptavidin HP, 5 x 1 ml. Category: Chromatography Systems & Accessories, Systems....

Biology Products:

Captivate disposable sample chamber - for Captivate magnetic yoke - set of 10 from Molecular Probes (Invitrogen)Mouse Anti-Human MOC31 Monoclonal Antibody, Unconjugated from AbD Serotec Complete Adjuvant from Santa Cruz Biotechnology, Inc.HiTrap Streptavidin HP from GE Healthcare, formerly Amersham Biosciences